Myths vs facts: Triglyceride senken and Allergie

The question of myths vs facts about lowering triglycerides and allergies requires careful separation of marketing from evidence. There is no robust evidence that a single genetic variant (e.g., from a DTC DNA test) can guide triglyceride reduction or predict allergy risk in a clinically actionable way. Triglyceride levels are primarily modulated by diet (refined carbs, fats), physical activity, and weight; omega-3 fatty acids show moderate benefit but with high interindividual variability. Allergies are highly polygenic and environment-driven; a single SNP (e.g., in VDR) has negligible predictive power. Many DTC claims are based on mechanistic or GWAS associations with tiny effect sizes (e.g., beta 0.07 for COMT stress resilience). A lipid panel is useful, but interpretation requires clinical context. Safety note: self-supplementation without medical advice (e.g., high-dose omega-3) may cause bleeding risk or interactions.